• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Deletions in env gene of HIV-1 in AIDS patients treated with highly active antiretroviral therapy (HAART).

作者信息

Saurya Shreesh, Lichtenstein Zelman, Karpas Abraham

机构信息

Department of Haematology, University of Cambridge Clinical School, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

出版信息

J Med Virol. 2003 Oct;71(2):167-72. doi: 10.1002/jmv.10459.

DOI:10.1002/jmv.10459
PMID:12938189
Abstract

Many AIDS patients retain high CD4+ T-cell counts despite a significant increase in PCR viral load after varied periods of treatment on drug combination with Highly Active Antiretroviral Therapy (HAART). In order to investigate this contradictory phenomenon, we assayed for infectious HIV-1 from the plasma of such patients. Since the biological assays failed to reveal any infectious virus, we undertook molecular characterization of the plasma HIV-1 genes. These studies revealed large deletions in the env gene of the free virus, while there were no deletions in the proviral DNA obtained from the infected cells of the patients' blood. This suggests that the viral particles produced and released by the infected cells during the HAART treatment have deletions in the env gene. The deletions were large enough to produce an envelop-deficient virus, which can readily explain why it is not infectious. Such a defective virus is the most likely explanation for its failure to infect the T-cells, which in turn lead to the discordance between the high PCR viral load and stable CD4+ T cell counts.

摘要

相似文献

1
Deletions in env gene of HIV-1 in AIDS patients treated with highly active antiretroviral therapy (HAART).
J Med Virol. 2003 Oct;71(2):167-72. doi: 10.1002/jmv.10459.
2
Defective rev response element (RRE) and rev gene in HAART treated AIDS patients with discordance between viral load and CD4+ T-cell counts.接受高效抗逆转录病毒治疗(HAART)的艾滋病患者中,病毒载量与CD4 + T细胞计数不一致,存在缺陷的病毒调节反应元件(RRE)和病毒调节蛋白(Rev)基因。
J Clin Virol. 2005 Aug;33(4):324-7. doi: 10.1016/j.jcv.2005.05.003.
3
Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.尽管病毒发生了进化且耐药基因型的选择非常有限,但高效抗逆转录病毒疗法仍能长期抑制血浆病毒血症。
J Med Virol. 2004 Jul;73(3):350-61. doi: 10.1002/jmv.20098.
4
Molecular biological assessment methods and understanding the course of the HIV infection.分子生物学评估方法与对HIV感染病程的理解
APMIS Suppl. 2003(114):1-37.
5
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.血浆病毒载量≤20拷贝/毫升的HIV-1感染患者的残余病毒血症与可溶性免疫激活标志物的血液水平升高有关。
Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.
6
Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy.在成功进行两年高效抗逆转录病毒治疗后,未发现HIV-1感染患者体内蛋白酶发生进化的证据。
J Infect Dis. 2004 Apr 15;189(8):1444-51. doi: 10.1086/382485. Epub 2004 Apr 5.
7
Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.携带CCR5基因Delta32缺失的HIV-1感染患者对高效抗逆转录病毒疗法的病毒学应答改善。
HIV Med. 2007 May;8(4):213-9. doi: 10.1111/j.1468-1293.2007.00455.x.
8
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.接受高效抗逆转录病毒治疗(HAART)失败的HIV-1感染患者血浆RNA和全血DNA中的抗逆转录病毒基因型耐药性
J Med Virol. 2008 Oct;80(10):1695-706. doi: 10.1002/jmv.21261.
9
Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.在一个加勒比发展中国家的非临床试验环境中,对高效抗逆转录病毒疗法的免疫和病毒学反应。
HIV Med. 2006 Mar;7(2):99-104. doi: 10.1111/j.1468-1293.2006.00347.x.
10
Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART.基因分析揭示了接受高效抗逆转录病毒治疗(HAART)的患者经连续采样的T淋巴细胞中具有结构的HIV-1群体。
Virology. 2006 Apr 25;348(1):35-46. doi: 10.1016/j.virol.2005.12.031. Epub 2006 Feb 7.

引用本文的文献

1
Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1.未受刺激的CD4+ T淋巴细胞摄取来自表达缺陷型HIV-1的细胞的外泌体后的细胞活化及HIV-1复制
Retrovirology. 2014 Jun 12;11:46. doi: 10.1186/1742-4690-11-46.